TuisME • NASDAQ
23andMe Holding Co.
$3,64
13 Jan., 13:24:54 GMT-5 · USD · NASDAQ · Vrywaring
AandeelVSA-gelyste effekHoofkantoor in VSA
Vorige sluiting
$3,84
Dagwisseling
$3,55 - $3,83
Jaarwisseling
$2,66 - $16,52
Markkapitalisasie
87,95 m USD
Gemiddelde volume
265,25 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD)Sep. 2024J/J-verandering
Inkomste
44,07 m-11,86%
Bedryfskoste
81,33 m-17,18%
Netto inkomste
-59,10 m21,48%
Netto winsgrens
-134,1110,91%
Wins per aandeel
EBITDA
-54,96 m21,06%
Effektiewe belastingkoers
0,07%
Totale bates
Totale aanspreeklikheid
(USD)Sep. 2024J/J-verandering
Kontant en korttermynbeleggings
126,60 m-50,62%
Totale bates
318,94 m-60,19%
Totale aanspreeklikheid
217,01 m23,31%
Totale ekwiteit
101,93 m
Uitstaande aandele
26,12 m
Prys om te bespreek
0,97
Opbrengs op bates
-42,89%
Opbrengs op kapitaal
-75,30%
Netto kontantverandering
(USD)Sep. 2024J/J-verandering
Netto inkomste
-59,10 m21,48%
Kontant van bedrywe
-40,93 m28,34%
Kontant van beleggings
-2,70 m2,63%
Kontant van finansiering
260,00 k-83,68%
Netto kontantverandering
-43,37 m25,18%
Beskikbare kontantvloei
-12,82 m59,90%
Meer oor
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell. Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008. The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Gestig
Apr. 2006
Werknemers
571
Search
Vee soektog uit
Maak soekkassie toe
Google-programme
Hoofkieslys